PCR-Based Ordered Genomic Libraries: a New Approach to Drug Target Identification for Streptococcus pneumoniae von BELANGER, Aimee E, LAI, Angel, BRACKMAN, Marcia A, LEBLANC, Donald J

Volltext

Comparison of biological and chemical assays for the quantitation of rifapentine in human plasma von Kenny, Michael T., Reynolds, Donald L., Brackman, Marcia A., Dulworth, Jacqueline K.

Volltext

Comparative in vitro activity of teicoplanin and vancomycin against united states teicoplanin clinical trial isolates of gram-positive cocci von Kenny, Michael T., Dulworth, Jacqueline K., Brackman, Marcia A.

Volltext

Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria von Kenny, Michael T., Mayer, Gerald D., Dulworth, Jacqueline K., Brackman, Marcia A., Farrar, Kim

Volltext

Exposure-adjusted safety analyses of the VISION phase 3 trial of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer von Chi, Kim N., Adra, Nabil, Garje, Rohan, Michalski, Jeff M., Lavalaye, Jules, Kempel, Mette Moe, Brackman, Marcia, Perraud, Kevin, Holder, Geoffrey, Armstrong, Andrew J.

Volltext

A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy von Kuo, Phillip H, Yoo, Don C, Avery, Ryan, Seltzer, Marc, Calais, Jeremie, Nagarajah, James, Weber, Wolfgang A, Fendler, Wolfgang P, Hofman, Michael S, Krause, Bernd J, Brackman, Marcia, Kpamegan, Euloge, Ghebremariam, Samson, Benson, Taylor, Catafau, Ana M, Kendi, Ayse T

Volltext

[ 177 Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial von Vaishampayan, Nitin, Morris, Michael J., Krause, Bernd J., Vogelzang, Nicholas J., Kendi, Ayse T., Nordquist, Luke T., Calais, Jeremie, Nagarajah, James, Beer, Tomasz M., El-Haddad, Ghassan, Brackman, Marcia, Desilvio, Michelle, Messmann, Richard Adam, Sartor, A. Oliver, Fizazi, Karim

Volltext

[ 68 Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [ 177 Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy von Kuo, Phillip, Hesterman, Jacob, Rahbar, Kambiz, Kendi, Ayse T., Wei, Xiao X., Fang, Bruno, Adra, Nabil, Armstrong, Andrew J., Garje, Rohan, Michalski, Jeff M., Ghebremariam, Samson, Brackman, Marcia, Wong, Connie, Benson, Taylor, Vogelzang, Nicholas J.

Volltext

Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer von Chi, Kim N., Armstrong, Andrew J., Krause, Bernd J., Herrmann, Ken, Rahbar, Kambiz, de Bono, Johann S., Adra, Nabil, Garje, Rohan, Michalski, Jeff M., Kempel, Mette M., Fizazi, Karim, Morris, Michael J., Sartor, Oliver, Brackman, Marcia, DeSilvio, Michelle, Wilke, Celine, Holder, Geoffrey, Tagawa, Scott T.

Volltext

A VISION Substudy of Reader Agreement on 68 Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177 Lu-PSMA-617 Radioligand Therapy von Kuo, Phillip H, Yoo, Don C, Avery, Ryan, Seltzer, Marc, Calais, Jeremie, Nagarajah, James, Weber, Wolfgang A, Fendler, Wolfgang P, Hofman, Michael S, Krause, Bernd J, Brackman, Marcia, Kpamegan, Euloge, Ghebremariam, Samson, Benson, Taylor, Catafau, Ana M, Kendi, Ayse T

Volltext

Safety Analyses of the Phase 3 VISION Trial of 177LuLu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer von Chi, Kim N, Armstrong, Andrew J, Krause, Bernd J, Herrmann, Ken, Rahbar, Kambiz, de Bono, Johann S, Adra, Nabil, Garje, Rohan, Michalski, Jeff M, Kempel, Mette M, Fizazi, Karim, Morris, Michael J, Sartor, Oliver, Brackman, Marcia, DeSilvio, Michelle, Wilke, Celine, Holder, Geoffrey, Tagawa, Scott T

Volltext

Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study von Spencer, Kimberly, Colvin, Kelly, Braunecker, Brad, Brackman, Marcia, Ripley, Joyce, Hines, Paul, Skrivanek, Zachary, Gaydos, Brenda, Geiger, Mary Jane

Volltext

Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans von Antony, Kelly K., Lewis, Eric W., Kenny, Michael T., Dulworth, Jacqueline K., Brackman, Marcia B., Kuzma, Ron, Yuh, Lianng, Eller, Mark G., Thompson, Gary A.

Volltext

Pharmacokinetics and bioavailability of a new formulation of tecoplanin following intrayenous and intramuscular administration to humans von Antony, Kelly K., Lewis, Eric W., Kenny, Michael T., Dulworth, Jacqueline K., Brackman, Marcia B., Kuzma, Ron, Yuh, Lianng, Eller, Mark G., Thompson, Gary A.

Volltext